DSGN vs DRS: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

DRS has stronger fundamentals based on our AI analysis.

DSGN
Design Therapeutics, Inc.
STRONG SELL
92%
Confidence
VS
DRS
Leonardo DRS, Inc.
BUY
78%
Confidence

DSGN vs DRS Fundamental Comparison

Metric DSGN DRS
Revenue $0.0 $3.6B
Net Income $-69.8M $278.0M
Net Margin N/A 7.6%
ROE -32.8% 10.2%
ROA -30.9% 6.2%
Current Ratio 17.14x 1.89x
Debt/Equity 0.00x 0.13x
EPS $-1.22 $1.03

Green = Better metric | Red = Weaker metric

View Full DSGN Analysis →
View Full DRS Analysis →

You Might Also Compare

DSGN vs AAPL DRS vs MSFT DSGN vs GOOGL DRS vs AMZN

DSGN vs DRS: Frequently Asked Questions

Is DSGN or DRS a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), DRS has stronger fundamentals. DSGN is rated STRONG SELL (92% confidence) while DRS is rated BUY (78% confidence). This is not investment advice.

How does DSGN compare to DRS fundamentally?

Design Therapeutics, Inc. has ROE of -32.8% vs Leonardo DRS, Inc.'s 10.2%. Net margins are N/A vs 7.6% respectively.

Which stock pays higher dividends, DSGN or DRS?

DSGN has a dividend yield of N/A or no dividend while DRS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in DSGN or DRS for long term?

For long-term investing, consider that DSGN has STRONG SELL rating with 92% confidence, while DRS has BUY rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about DSGN vs DRS?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For DSGN vs DRS, the AI consensus favors DRS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.